您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > (R)-ND-336
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
(R)-ND-336
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
(R)-ND-336图片
CAS NO:2252493-33-5
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
(R)-ND-336 是一种有效的选择性MMP-9抑制剂,Ki为 19 nM。(R)-ND-336 抑制 MMP-2 (Ki=127 nM) 和 MMP-14 (Ki=119 nM)。(R)-ND-336 具有用于糖尿病足溃疡 (DFUs) 研究的潜力。
生物活性

(R)-ND-336 is a potent and selectiveMMP-9inhibitor with aKiof 19 nM. (R)-ND-336 inhibitsMMP-2(Ki=127 nM) andMMP-14(Ki=119 nM). (R)-ND-336 has the potential for diabetic foot ulcers (DFUs) research[1].

IC50& Target[1]

MMP-9

19 nM (Ki)

MMP-2

127 nM (Ki)

MMP-14

119 nM (Ki)

体外研究
(In Vitro)

(R)-ND-336 poorly inhibits other MMPs (Ki>100 μM). (R)-ND-336 has a long residence time (the time the inhibitor is bound to MMP-9, calculated as 1/koff) of 300 min[1].
A favorable IC50value of 143 μM afforded a therapeutic index (IC50/Kifor MMP-9) ratio of 7530, indicating that (R)-ND-336 is not cytotoxic[1].

体内研究
(In Vivo)

(R)-ND-336 (50 μg/wound/day for 14 days) accelerates wound healing faster[1].
(R)-ND-336 has an AUC of 1.3 μMomin after topical administration and 35 μMomin following intravenous dosing, for an AUCtop/AUCivratio of 3.7%, indicating minimal absorption after topical administration in db/db mice[1].

Animal Model:Female db/db mice (BKS.Cg-Dock7m+/+Leprdb/J, 8-weeks old, ~40 g body weight)[1]
Dosage:50 μg
Administration:Wound; once a day for 14 days
Result:Accelerated wound healing faster and showed complete inhibition of MMP-9.
分子量

371.90

Formula

C16H18ClNO3S2

CAS 号

2252493-33-5

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.